AbbVie ESG SVP talking about the *ethics* of how they achieve their breakthroughs...I would think the ethics of how many people could benefit from a drug would play into ESG considerations...IF they really mean it (notice the caps)
https://www.theatlantic.com/sponsored/abbvie-...6Srhx-puxg